Photo from Guru P. Sonpavde/X
Apr 11, 2024, 11:56
Guru P. Sonpavde: AACR – Many promising options for Phase I clinical trials
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X/Twitter:
“AACR24 AACR – Many promising options for Phase I clinical trials – searching for the best trials for our rapidly growing program AdventHealth Central Florida cancer Institute, Orlando, Florida– eager to explore collaborations!”
Source: Guru P. Sonpavde/X